Orthopaedic surgery in the palliation of cancer

2021 ◽  
pp. 839-848
Author(s):  
Mohamed Yakoub ◽  
John Healey

Metastatic spread of cancer to bone is frequent and causes pain, disability, and functional limitation. Non-surgical treatments such as chemotherapy and hormone therapy are effective in early disease. Administration of bisphosphonates or osteoprotegerin inhibitors prevent new ‘bone events’, thereby avoiding pain, radiation, and surgery. Radiotherapy arrests disease and relieves pain in many cases. Surgery is needed when the bone is weak or fractured. It effectively relieves pain and preserves function by bypassing the deficient bone with site-specific reconstructive surgery. Surgery should be selected based on projections of patient survival. New tools to make these projections are now available (https://www.pathfx.org/). New targeted drug therapies appear to be changing metastatic bone disease into a more chronic condition. This will alter the management of local disease in many histological subtypes of metastatic cancers.

Author(s):  
John H. Healey ◽  
David McKeown

Metastatic spread of cancer to bone is frequent and causes pain, disability, and functional limitation. New understanding of the homing method of cancer cells to bone and the mechanism of cancer production of pain raise possible new treatment strategies. Non-surgical treatments such as chemotherapy and hormone therapy are effective in early disease. Bisphosphonates and inhibition of osteoprotegerin prevent progression of bone lesions and avoid pain, radiation, and surgery. Radiotherapy arrests disease and relieves pain in many cases. Surgery is needed when the bone is weak or fractured. It effectively relieves pain and preserves function. It usually requires replacing or bypassing the deficient bone with site-specific reconstructive surgery. Surgery should be selected based on projections of patient survival. New tools to make these projections have been validated and are now available. New targeted drug therapies appear to be changing metastatic bone disease into a more chronic condition. This will alter the management of local disease in many histological subtypes of metastatic cancers.


2021 ◽  
Vol 28 (4) ◽  
pp. 2731-2740
Author(s):  
Aaron Gazendam ◽  
Daniel Axelrod ◽  
David Wilson ◽  
Michelle Ghert

The pelvis is a common site of metastatic bone disease. Peri-acetabular lesions are particularly challenging and can cause severe pain, disability and pathologic fractures. Surgical management of these lesions has historically consisted of cementoplasty for contained lesions and Harrington reconstructions for larger, more destructive lesions. Due to the limitations of these procedures, a number of novel procedures have been developed to manage this challenging problem. Percutaneous techniques—including acetabular screw fixation and cementoplasty augmented with screws—have been developed to minimize surgical morbidity. Recent literature has demonstrated a reliable reduction in pain and improvement in function in appropriately selected patients. Several adjuncts to the Harrington procedure have been utilized in recent years to reduce complication rates. The use of constrained liners and dual mobility bearings have reduced the historically high dislocation rates. Cage constructs and porous tantalum implants are becoming increasingly common in the management of large bony defects and destructive lesions. With novel and evolving surgical techniques, surgeons are presented with a variety of surgical options to manage this challenging condition. Physicians must take into account the patients’ overall health status, oncologic prognosis and anatomic location and extent of disease when developing an appropriate surgical plan.


Bone sarcomas 296 Soft tissue sarcomas 300 Surgical treatments 302 Metastatic bone disease (MBD) 306 Bone sarcomas are extremely rare, with less than 550 new cases per annum in the UK. They account for only 0.2% of all new cancers, but 5% of childhood cancers. The main types of bone sarcoma/tumour are:...


2014 ◽  
Author(s):  
Krystallenia Alexandraki ◽  
Maria Chrysochoou ◽  
Maria Kaltsatou ◽  
Eleftherios Chatzellis ◽  
Marina Tsoli ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (11) ◽  
pp. 2581
Author(s):  
Michala Skovlund Sørensen ◽  
Michael Mørk Petersen

The current era within the field of surgical treatment of metastatic bone disease (MBD) is best described as the beginning of a paradigm shift [...]


Sign in / Sign up

Export Citation Format

Share Document